Newsroom

News

Mild or asymptomatic infections with the SARS coronavirus-2 are often not detected. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig is coordinating a nationwide study to determine the spread of antibodies against SARS-CoV-2. Population samples will be examined in ten selected regions until summer 2021. From 14 October, around 3000 test persons from the city and district of Osnabrück will be invited to take part in the antibody test.

14.10.2020

HZI Campus

News

In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study was published on the preprint platform SSRN in July 2020. The results have now been peer-reviewed and were published in the journal EMBO Molecular Medicine.

08.10.2020

HZI Campus

News

The Royal Swedish Academy of Sciences has awarded this year’s Nobel Prize in Chemistry to Emmanuelle Charpentier, former Head of the Department “Regulation in Infection Biology” at the Helmholtz Centre for Infection Research (HZI), Braunschweig, and Professor at the Hannover Medical School, Hannover, for her groundbreaking work on the CRISPR-Cas9 gene editing technology. She shares the prize with Jennifer A. Doudna.

07.10.2020

HZI Campus

News

Even though we have been living with the COVID- pandemic for more than half a year, there are still many unanswered questions and major uncertainties regarding further infection. How will the epidemic develop in Germany – especially during the upcoming flu season and the cold autumn and winter months? Which strategies are particularly effective in containing the rising number of infections in Germany and worldwide? What has proved successful in recent months? What properties of SARS-CoV- are now understood? And what measures can be imposed for the population and the economy without restricting social life too much?

24.09.2020

HZI Campus

News

Many SARS-coronavirus-2 infections are mild or completely asymptomatic and are therefore not detected. This makes it difficult to assess pandemic trends, prevention strategies and mortality rates. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. In a nationwide study, the Helmholtz Centre for Infection Research (HZI) in Braunschweig is using regional samples to investigate the spread of antibodies against the novel coronavirus. The study examines about 3000 test persons in the urban region of Aachen from 9th September 2020.

09.09.2020

HZI Campus

News

The European Research Council (ERC) awards three scientists from the Helmholtz Centre for Infection Research (HZI) with an ERC Starting Grant. The grants of up to 1.5 million Euros over a period of five years will be awarded to Jun Prof Neva Caliskan from the Helmholtz Institute for RNA-based Infection Research (HIRI), Jun Prof Gregor Fuhrmann from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Prof Yang Li from the Centre for Individualised Infection Medicine (CiiM).

03.09.2020

HZI Campus

CiiM

HIPS

HIRI

Back to the first page
...
57
58
59
60
...
147

HZI in the media

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025

Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025

World Today News

Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

19.09.2025

Verband Deutscher Biologen e.V.

purposes.

Researchers at the HIRI, a site of the Braunschweig Helmholtz Center for Infection Research (HZI), in cooperation with the Julius

19.09.2025

NewsBreak

... ihr Team vom Helmholtz-Institut für One Health (HIOH) in Greifswald – einem Standort des Helmholtz-Zentrums ...

18.09.2025

Management & Krankenhaus

... der TU Braunschweig, dem Braunschweig Integrated Centre of Systems Biology (BRICS) und dem Helmholtz-Zentrum für ...

15.09.2025

DeutschesGesundheitsPortal

Das Institut ist ein Teil des rennommierten Helmholtz-Zentrums für Infektionsforschung ...

11.09.2025

NDR Norddeutscher Rundfunk

... gearbeitet werden soll. Greifswald (dpa/mv) - In einem eigenen Gebäude sollen Forscher des Helmholtz-Instituts ...

11.09.2025

n-tv

Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einem Standort des Braunschweiger Helmholtz- ...

11.09.2025

MTA Dialog

Studie und Hersteller des Prüfpräparats. Das Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) war bei ...

11.09.2025

Kölner News Journal

at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Institute of Molecular Infection Biology (IMIB) in Würzburg has

10.09.2025

Phys.org

Leiter der Abteilung Chemische Biologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig www.helmholtz-hzi.de ...

10.09.2025

BR Bayerischer Rundfunk

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.